Year: 2012
-
September 27, 2012
Target acquired for aggressive tumor
New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified. -
September 26, 2012
LifeFlight goes pink for breast cancer awareness
-
September 25, 2012
Cell entry ports for cold virus
The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells. -
September 24, 2012
Construction work to affect Medical Center Drive
-
September 24, 2012
Little evidence supports medical treatment options for adolescents with autism
Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population. -
September 21, 2012
VU, Bristol-Myers to collaborate on Parkinson’s therapies
Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.